TOP STORY
Ronin Recruits Protein Allies to Sustain Embryonic Stem Cell Growth
Ronin, crucial to the self-renewal of embryonic stem cells, and a co-regulator called Hcf-1 bind to a small strand of DNA called a hyperconserved enhancer element to control a gene "program" that stimulates growth of stem cells and may even play a role in cancer. [Press release from the Baylor College of Medicine discussing online prepublication in Genes and Development]
|
SCIENCE NEWS
Chromosomal Variations Found in Early Passage Female Embryonic Stem Cells
Scientists have uncovered that variations in X chromosome inactivation take place in very early passages of female human embryonic stem cells lines. [Press release from EurekAlert! discussing online prepublication in PLoS One]
University of Texas Medical Branch Grows Lung from ‘Skeletons’
Specialists in the field of tissue engineering have been frustrated by the problem of coaxing undifferentiated stem cells to develop into the specific cell types that populate different locations in the lung. Now, researchers have demonstrated a potentially revolutionary solution to this problem. [Press release from the University of Texas Medical Branch discussing online prepublication in Tissue Engineering Part A]
Building a Substitute Pancreas for Diabetics
Implants containing specially wrapped insulin-producing cells derived from embryonic stem cells can regulate blood sugar in mice for several months. [Press release from MIT Technology Review discussing research presented at the 8th Annual Meeting of the International Society for Stem Cell Research]
|
POLICY NEWS
U.S. Appeals Court Reinstates Stem Cell Suit
A U.S. appeals court reinstated a lawsuit that challenges an Obama administration policy for federal funding of some human embryonic stem cell research. [Court of Appeals, United States]
NIH Director Formalizes Rejection of Diseased Stem Cell Lines
The director of the National Institutes of Health (NIH) approved eight more human embryonic stem cell lines for federal funding. His decision brings to 75 those lines now available to NIH-supported researchers under President Barack Obama's liberalized, 2009 policy. [National Institutes of Health, United States]
Research Budgets Face Austerity in 2012
The National Institutes of Health and other life sciences and biomedical research funding agencies will need to trim their budgets for 2012, which are to be planned over the summer, to satisfy a White House that is now stressing deficit reduction and belt-tightening after two years of stimulus funding-boosted research budgets. [The Office of Management and Budget, United States]
The Reality of Human Stem Cell Research in Europe
A new report from the European Science Foundation examines the key scientific questions for human stem cell research in the context of the rapidly emerging field of regenerative medicine. [European Science Foundation, European Union]
Public Wants Synthetic Biology Regulated, Survey Says
According to the most extensive public survey yet, the British public are at ease with the idea of synthetic biology -- but only if it is responsibly regulated. [Biotechnology and Biological Sciences Research Council, United Kingdom]
Strong Medicine for French Research
The medical-research adviser to France's president aims to shift power and money to universities. [National Research Agency, France]
The 7th Annual TOPRA (The Organization for Professionals in Regulatory Affairs) Symposium
This annual symposium is for all those involved within regulatory affairs and brings together representatives of industry and the regulatory agencies and the European Commission to discuss and understand today’s regulatory issues and debate the future plans for regulation. [Medicines and Healthcare Products Regulatory Agency, United Kingdom]
Center for Scientific Review; Notice of Closed Meetings [National Institutes of Health, Untied States]
Biophysical and Biomechanical Aspects of Embryonic Development (R01) (PAR-10-221) [National Heart, Lung, and Blood Institute, United States]
Biophysical and Biomechanical Aspects of Embryonic Development (R21) (PAR-10-222) [National Heart, Lung, and Blood Institute, United States]
Science Board Advisory Committee; Notice of Meeting [Docket No. FDA-2010-N-0001] [Food and Drug Administration, United States]
Implementation of the Biologics Price Competition and Innovation Act of 2009 [Food and Drug Administration, United States]
Public Meeting Notice: Maryland Stem Cell Research Commission [Maryland Stem Cell Research Commission, United States]
|
|
EVENTS
Worldwide Innovative Networking (WIN) Symposium in Personalized Cancer Medicine
July 7-9, 2010
Paris, France
United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom
2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
August 2-4, 2010
Singapore
Select Biosciences 3rd Annual Stem Cells Europe Conference
August 24-25, 2010
Edinburgh, Scotland
Select Biosciences Inaugural Cellular Therapy Summit
August 24-25, 2010
Edinburgh, Scotland
International Society for Cellular Therapy (ISCT) - Europe 2nd Regional Meeting
September 11-14, 2010
Belgirate, Italy
Stem Cells USA & Regenerative Medicine Congress 2010
September 13-15, 2010
Philadelphia, United States
Tissue Engineering & Regenerative Medicine International Society (TERMIS) - Asia Pacific 2010
September 15-17, 2010
Sydney, Australia
5th World Congress on Preventive & Regenerative Medicine (WCRM) 2010
October 5-7, 2010
Hannover, Germany
Fraunhofer Life Science Symposium Leipzig 2010
October 29-30, 2010
Leipzig, Germany
Select Biosciences 2nd International Forum on Stem Cells
November 12-13, 2010
Tianjin, China
Stem Cell Network 10th Annual Scientific Meeting
November 22-24, 2010
Calgary, Canada
Tissue Engineering & Regenerative Medicine International Society (TERMIS) - North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States
Stem Cells World Congress
January 24-25, 2011
San Diego, United States
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Senior Scientist - Magnetic Cell Separation (STEMCELL Technologies)
Business Development Manager Europe - Cell Therapy Products (Pall Corporation)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with ESC & iPSC News.
Visit here to post your career opportunities.
|
|
Suite 201 - 375 West Fifth Avenue
Vancouver, BC V5Y 1J6, Canada
|
